SARS-CoV-2 multisystem inflammatory syndrome in an adult presenting with polyarthritis treated with anakinra.

Chalasani, Varun; Parameswaran, Padmini; Cherico, Adriani; Villgran, Vipin; Lowther, Holly; Marco, Joanna

Chalasani, Varun; Parameswaran, Padmini; Cherico, Adriani; Villgran, Vipin; Lowther, Holly; Marco, Joanna.

Chalasani V; Department of Internal Medicine.
Parameswaran P; Department of Rheumatology.
Cherico A; Department of Internal Medicine.
Villgran V; Department of Pulmonology, Allegheny Health Network, Pittsburgh, PA, USA.
Lowther H; Department of Rheumatology.
Marco J; Department of Rheumatology.

Rheumatology (Oxford) ; 61(2): e33-e34, 2022 02 02.

Article in English | MEDLINE | ID: covidwho-1402563

Subject(s)

Arthritis/drug therapy; Arthritis/virology; COVID-19 Drug Treatment; COVID-19/complications; Interleukin 1 Receptor Antagonist Protein/therapeutic use; Systemic Inflammatory Response Syndrome/drug therapy; Antirheumatic Agents/therapeutic use; Glucocorticoids/therapeutic use; Humans; Male; Methylprednisolone/therapeutic use; Middle Aged; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis / Systemic Inflammatory Response Syndrome / Interleukin 1 Receptor Antagonist Protein / COVID-19 / COVID-19 Drug Treatment Type of study: Case report Topics: Long Covid Limits: Humans / Male / Middle aged Language: English Journal: Rheumatology (Oxford) Journal subject: Rheumatology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google